The credit crunch: A capital bypass for life sciences?
Over at VentureBeat proper, Matt highlights a theory advanced by venture capitalist Keith Benjamin, who argues that the credit crunch now threatening the private-equity boom may have the unexpected effect of boosting returns in technology investments. (Keith puts this all down in his own words on his personal blog and in this contributed piece at VentureBeat.)
Turns out a few people have also been wondering whether a deflating private-equity bubble might also redirect capital to the… Continue Reading